Cargando…
A policy analysis of the national phenylketonuria screening program in Iran
BACKGROUND: Phenylketonuria (PKU) screening is a public health measure taken to diagnose and treat the patients with PKU to prevent severe neurological disorders in them. The present study was aimed at analyzing the policies of the national PKU screening (NaPS) program in Iran. METHODS: PKU screenin...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863318/ https://www.ncbi.nlm.nih.gov/pubmed/33546689 http://dx.doi.org/10.1186/s12913-021-06116-w |
_version_ | 1783647469141229568 |
---|---|
author | Heidari, Alireza Arab, Mohammad Damari, Behzad |
author_facet | Heidari, Alireza Arab, Mohammad Damari, Behzad |
author_sort | Heidari, Alireza |
collection | PubMed |
description | BACKGROUND: Phenylketonuria (PKU) screening is a public health measure taken to diagnose and treat the patients with PKU to prevent severe neurological disorders in them. The present study was aimed at analyzing the policies of the national PKU screening (NaPS) program in Iran. METHODS: PKU screening program policies were analyzed in compliance with the policy triangle model. Document review and 38 semi-structured interviews were used for data collection. Document review data were analyzed using content analysis, and interview data were analyzed using framework analysis. RESULTS: The national PKU screening (NaPS) program was a decision made at the genetics department of Ministry of Health and Medical Education (MOHME) in Iran. Many internal and external stakeholders were involved in it and valid evidence was used to formulate the policies. Despite some opposition and insufficient support, the program was implemented due to the continuous persistence of parents, interested executives, formulated valid content and a top-down approach. The main barriers included rapid substitution of managers, shortage of Phe-free milk, little awareness of patients’ families, social stigma, and inadequate co-operation of some hospital administrators. CONCLUSIONS: The policy triangle framework contributed to explaining the different components of the PKU screening program. A successful PKU screening program requires more stability of senior managers in MOHME, enough human resources and Phe-free milk, educating patients’ families, and commitment of hospitals administrators. Meanwhile, all the stakeholders need to be involved in the program effectively. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12913-021-06116-w. |
format | Online Article Text |
id | pubmed-7863318 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-78633182021-02-05 A policy analysis of the national phenylketonuria screening program in Iran Heidari, Alireza Arab, Mohammad Damari, Behzad BMC Health Serv Res Research Article BACKGROUND: Phenylketonuria (PKU) screening is a public health measure taken to diagnose and treat the patients with PKU to prevent severe neurological disorders in them. The present study was aimed at analyzing the policies of the national PKU screening (NaPS) program in Iran. METHODS: PKU screening program policies were analyzed in compliance with the policy triangle model. Document review and 38 semi-structured interviews were used for data collection. Document review data were analyzed using content analysis, and interview data were analyzed using framework analysis. RESULTS: The national PKU screening (NaPS) program was a decision made at the genetics department of Ministry of Health and Medical Education (MOHME) in Iran. Many internal and external stakeholders were involved in it and valid evidence was used to formulate the policies. Despite some opposition and insufficient support, the program was implemented due to the continuous persistence of parents, interested executives, formulated valid content and a top-down approach. The main barriers included rapid substitution of managers, shortage of Phe-free milk, little awareness of patients’ families, social stigma, and inadequate co-operation of some hospital administrators. CONCLUSIONS: The policy triangle framework contributed to explaining the different components of the PKU screening program. A successful PKU screening program requires more stability of senior managers in MOHME, enough human resources and Phe-free milk, educating patients’ families, and commitment of hospitals administrators. Meanwhile, all the stakeholders need to be involved in the program effectively. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12913-021-06116-w. BioMed Central 2021-02-05 /pmc/articles/PMC7863318/ /pubmed/33546689 http://dx.doi.org/10.1186/s12913-021-06116-w Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Heidari, Alireza Arab, Mohammad Damari, Behzad A policy analysis of the national phenylketonuria screening program in Iran |
title | A policy analysis of the national phenylketonuria screening program in Iran |
title_full | A policy analysis of the national phenylketonuria screening program in Iran |
title_fullStr | A policy analysis of the national phenylketonuria screening program in Iran |
title_full_unstemmed | A policy analysis of the national phenylketonuria screening program in Iran |
title_short | A policy analysis of the national phenylketonuria screening program in Iran |
title_sort | policy analysis of the national phenylketonuria screening program in iran |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863318/ https://www.ncbi.nlm.nih.gov/pubmed/33546689 http://dx.doi.org/10.1186/s12913-021-06116-w |
work_keys_str_mv | AT heidarialireza apolicyanalysisofthenationalphenylketonuriascreeningprograminiran AT arabmohammad apolicyanalysisofthenationalphenylketonuriascreeningprograminiran AT damaribehzad apolicyanalysisofthenationalphenylketonuriascreeningprograminiran AT heidarialireza policyanalysisofthenationalphenylketonuriascreeningprograminiran AT arabmohammad policyanalysisofthenationalphenylketonuriascreeningprograminiran AT damaribehzad policyanalysisofthenationalphenylketonuriascreeningprograminiran |